Mark Cuban Eyes Rare Disease Drugs for Cost Plus Drugs

Tech entrepreneur Mark Cuban is expanding his pharmaceutical company, Cost Plus Drugs, into the business of custom-made rare disease medicines. The move aims to shake up the market and capitalize on growing demand.